Genomic Surveillance for SARS-CoV-2 — China, September 26, 2022 to January 29, 2023
Shiwen Wang,
No information about this author
Peihua Niu,
No information about this author
Qiudong Su
No information about this author
et al.
China CDC Weekly,
Journal Year:
2023,
Volume and Issue:
5(7), P. 143 - 151
Published: Jan. 1, 2023
Introduction
The
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
has
generated
2,431
variants
over
the
course
of
its
global
transmission
past
3
years.
To
better
evaluate
genomic
variation
SARS-CoV-2
before
and
after
optimization
disease
2019
(COVID-19)
prevention
control
strategies,
we
analyzed
genetic
evolution
branch
composition
in
both
domestic
imported
cases
China
(the
data
from
Hong
Kong
Macau
Special
Administrativc
Regions
Taiwan,
were
not
included)
September
26,
2022
to
January
29,
2023.
Methods
Analysis
number
genome
sequences,
sampling
time,
dynamic
changes
evolutionary
branches,
origin,
clinical
typing
submitted
by
31
provincial-level
administrative
divisions
(PLADs)
Xinjiang
Production
Construction
Corp
(XPCC)
was
conducted
assess
accuracy
timeliness
variant
surveillance.
Results
From
2023,
20,013
valid
sequences
reported
China,
with
72
branches.
Additionally,
1,978
reported,
169
prevalence
Omicron
consistent
that
international
epidemic
variants.
Conclusions
This
study
provides
an
overview
China.
After
optimizing
COVID-19
no
novel
altered
biological
characteristics
or
public
health
significance
have
been
identified
since
December
1,
2022.
Language: Английский
The relative prevalence of the Omicron variant within SARS-CoV-2 infected cohorts in different countries: A systematic review
Aparajita Sarkar,
No information about this author
Sara Omar,
No information about this author
Aya Alshareef
No information about this author
et al.
Human Vaccines & Immunotherapeutics,
Journal Year:
2023,
Volume and Issue:
19(1)
Published: Jan. 2, 2023
The
Omicron
variant
of
SARS-CoV-2
was
detected
in
October
2021
and
exhibited
high
transmissibility,
immune
evasion,
reduced
severity
when
compared
to
the
earlier
variants.
lesser
vaccine
effectiveness
against
its
created
vaccination
hesitancy
among
public.
This
review
compiled
data
reporting
relative
prevalence
as
early
variants
give
an
insight
into
existing
variants,
which
may
shape
decisions
regarding
targets
newly
developed
vaccines.
Complied
revealed
more
than
90%
within
infected
cohorts
some
countries.
BA.1
subvariant
predominated
over
BA.2
during
stages
wave.
Moreover,
BA.4/BA.5
subvariants
were
South
Africa,
USA
Italy
between
April
2022.
It
is
therefore
important
develop
vaccines
that
protect
well
are
known
cause
severe
complications.
Language: Английский
SARS-CoV-2 Surveillance Through China Influenza Surveillance Information System — China, December 1, 2022 to February 12, 2023
Xiaoxu Zeng,
No information about this author
Yiran Xie,
No information about this author
Xiaokun Yang
No information about this author
et al.
China CDC Weekly,
Journal Year:
2023,
Volume and Issue:
5(7), P. 152 - 158
Published: Jan. 1, 2023
The
World
Health
Organization
(WHO)
proposed
using
influenza
surveillance
systems
to
carry
out
coronavirus
disease
2019
(COVID-19)
due
the
similarity
between
two
diseases
in
some
respiratory
symptoms.
To
assess
prevalence
of
COVID-19,
we
analyzed
influenza-like
illness
(ILI)
and
positive
rate
severe
acute
syndrome
2
(SARS-CoV-2)
detections
ILI
patients
reported
Surveillance
Information
System
(CNISIS)
since
late
2022.Data
related
were
by
national
sentinel
hospitals.
Positive
testing
for
SARS-CoV-2
viruses
was
conducted
real-time
reverse
transcription
polymerase
chain
reaction
(rRT-PCR)
detection
network
laboratories.
data
CNISIS.Beginning
on
December
12,
2022
(Week
50),
percentage
increased
dramatically,
peaking
Week
51
at
12.1%.
Subsequently,
began
decline
rapidly
from
52,
2022,
6,
2023
(February
6-12),
had
returned
levels
observed
beginning
2022.
From
1,
February
2023,
115,844
specimens
tested
both
virus.
Of
these,
30,381
(26.2%)
1,763
(1.5%)
tests
peaked
74.1%
around
23
25.Sentinel-based
surveillance,
previously
established
influenza,
is
an
effective
way
track
circulation
trend
during
community-level
epidemics.
There
no
co-prevalence
virus
outbreak
SARS-CoV-2,
even
winter
season.
However,
it
important
remain
vigilant
potential
rise
activities
following
COVID-19
epidemic.
Language: Английский
Surveillance and Analysis of SARS-CoV-2 Variant Importation — China, January–June 2022
Yenan Feng,
No information about this author
Xiang Zhao,
No information about this author
Zeyuan Yin
No information about this author
et al.
China CDC Weekly,
Journal Year:
2022,
Volume and Issue:
4(50), P. 1136 - 1142
Published: Jan. 1, 2022
The
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
Omicron
variant
is
the
dominant
circulating
strain
worldwide.
To
assess
importation
of
SARS-CoV-2
variants
in
mainland
China
during
epidemic,
genomic
surveillance
data
from
imported
disease
2019
(COVID-19)
cases
first
half
2022
were
analyzed.Sequences
submitted
January
to
July
2022,
with
a
collection
date
before
June
30,
incorporated.
proportions
as
well
relationships
between
origin
and
destination
each
case
analyzed.4,946
sequences
27
provincial-level
administrative
divisions
(PLADs),
median
submission
interval
was
within
1
month
after
collection.
In
3,851
good
quality,
recombinant
(XU)
4
subvariants
under
monitoring
(BA.4,
BA.5,
BA.2.12.1,
BA.2.13)
recorded,
3
them
BA.2.12.1)
caused
local
transmissions
later
than
that
recorded
surveillance.
dominated
shifted
BA.1
BA.2
then
BA.4
BA.5.
percentage
far
higher
Global
Initiative
on
Sharing
All
Influenza
Data
(GISAID).
Hong
Kong
Special
Administrative
Region,
China,
accounted
for
32.30%
sampled,
98.71%
BA.2.The
showed
intra-Omicron
evolution
all
introduced
into
multiple
times
different
locations.
Language: Английский
Systematic Genomic Surveillance of SARS-CoV-2 at Xiamen International Airport and the Port of Xiamen Reveals the Importance of Incoming Travelers in Lineage Diversity
Ruiluan You,
No information about this author
Ruotong Wu,
No information about this author
Xijing Wang
No information about this author
et al.
Viruses,
Journal Year:
2024,
Volume and Issue:
16(1), P. 132 - 132
Published: Jan. 17, 2024
Sever
Acute
Respiratory
Syndrome
Coronavirus-2
(SARS-CoV-2)
is
still
a
threat
to
human
health
globally
despite
the
World
Health
Organization
(WHO)
announcing
end
of
COVID-19
pandemic.
Continued
surveillance
SARS-CoV-2
at
national
borders
would
be
helpful
in
understanding
epidemics
novel
imported
variants
and
updating
local
strategies
for
disease
prevention
treatment.
This
study
focuses
on
among
travelers
entering
Xiamen
International
Airport
Port
from
February
August
2023.
A
total
97
sequences
223
cases
collected
12
different
countries
regions
were
identified
by
real-time
RT-PCR.
Next-generation
sequencing
was
used
generate
high-quality
complete
phylogenetic
population
dynamic
analysis.
The
revealed
dominant
shift
variant
distribution,
which
XBB
subvariant
(XBB.1.5,
XBB.1.16,
XBB.1.9,
XBB.2.3,
EG.5.1)
accounted
approximately
88.8%
sequenced
samples.
In
detail,
clades
23D
23E
26.2%
21.4%
samples,
respectively,
while
23B
(13.6%)
23F
(10.7%)
took
third
fourth
spots
order
sequences,
respectively.
Additionally,
XBB.2.3
first
mainland
Xiamen,
China
27
spatiotemporal
analyses
recent
viral
genome
limited
number
into
provide
valuable
insights
situation
surrounding
highlight
importance
sentinel
border
screening
incoming
travelers,
serves
as
an
early
warning
system
presence
highly
transmissible
circulating
lineages.
Language: Английский
Prevalence and diversity of imported severe acute respiratory syndrome coronavirus 2 variants in China, 2021–2022
Yenan Feng,
No information about this author
Xiang Zhao,
No information about this author
Zhixiao Chen
No information about this author
et al.
Journal of Medical Virology,
Journal Year:
2024,
Volume and Issue:
96(5)
Published: May 1, 2024
The
causative
agent
of
coronavirus
disease
2019
(COVID-19),
known
as
severe
acute
respiratory
syndrome
2
(SARS-CoV-2),
has
spread
accumulatively
to
240
countries
and
continues
evolve.
To
gain
a
comprehensive
understanding
the
epidemiological
characteristics
imported
variants
in
China
their
correlation
with
global
circulating
variants,
genomic
surveillance
data
from
11
139
COVID-19
cases
submitted
by
Chinese
provincial
CDC
laboratories
between
2021
2022
were
analyzed.
Consensus
sequences
underwent
rigorous
quality
checks,
followed
amino
acid
mutations
analysis
using
Nextclade.
Sequences
satisfactory
control
status
classified
according
Pango
nomenclature.
results
showed
that
dominant
reflected
epidemic
trend.
An
increase
number
SARS-CoV-2
lineages
monitored
second
half
2022,
Omicron
subvariants
changed
ancestral
BA.5
BA.2
into
containing
key
spike
protein.
There
was
significant
variation
detection
among
continents
(χ
Language: Английский
Associations between genetic mutations in different SARS-CoV-2 strains and negative conversion time of viral RNA among imported cases in Hangzhou: A cross-sectional study
Yì Wáng,
No information about this author
Hua Yu,
No information about this author
Tao Zhang
No information about this author
et al.
Virus Research,
Journal Year:
2024,
Volume and Issue:
345, P. 199400 - 199400
Published: May 20, 2024
Previous
studies
on
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
have
focused
factors
that
influence
the
achievement
of
negative
conversion
viral
RNA.
This
study
aimed
to
investigate
effects
genetic
mutations
in
different
SARS-CoV-2
strains
time
(NCT)
among
imported
cases
Hangzhou,
Zhejiang
Province,
China,
order
provide
valuable
insights
for
developing
targeted
epidemic
prevention
guidelines.
Language: Английский
COVID-19 outbreaks caused by different SARS-CoV-2 variants: a descriptive, comparative study from China
Cao Chen,
No information about this author
Yenan Feng,
No information about this author
Zeyuan Yin
No information about this author
et al.
Frontiers in Public Health,
Journal Year:
2024,
Volume and Issue:
12
Published: Dec. 12, 2024
Objectives
To
understand
the
epidemic
characteristics
of
various
SARS-CoV-2
variants,
we
mainly
focus
on
analyzing
general
profiles,
viral
mutation,
and
evolution
COVID-19
outbreaks
caused
by
different
variants
concern
(VOCs)
in
China
as
August
2022.
Methods
We
systematically
sorted
out
profiles
VOCs
China,
compared
differences
Delta
Omicron
VOCs,
analyzed
mutational
changes
subvariants
between
same
outbreak
outbreaks.
Findings
By
15
2022,
a
total
2,
33,
124
Alpha,
Delta,
respectively,
were
reported
regions
China.
In
terms
number
outbreaks,
extent
affected
areas,
confirmed
cases,
more
widespread
than
other
variants.
The
most
frequently
circulating
PANGO
lineages
B.1.617.2
AY.122
BA.2.2.1,
BA.2,
BA.2.2,
BA.5
for
VOCs.
Additional
mutations
genome
strain
observed
with
longer
duration
higher
numbers
infections.
Conclusion
Through
comprehensive
analysis
influences,
found
continued
to
evolve
within
across
occurring
locations
or
at
times.
These
findings
suggest
that
rapidly
containing
an
virus
can
not
only
reduce
spread
but
also
delay
virus’s
mutation
frequency.
Language: Английский